STERIS plc (NYSE:STE) Shares Sold by LPL Financial LLC

LPL Financial LLC lessened its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 66.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 35,704 shares of the medical equipment provider's stock after selling 69,976 shares during the period. LPL Financial LLC's holdings in STERIS were worth $7,339,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in STE. Avalon Trust Co purchased a new stake in STERIS in the fourth quarter valued at approximately $30,000. Human Investing LLC acquired a new position in shares of STERIS in the 4th quarter valued at $31,000. Anfield Capital Management LLC increased its holdings in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after acquiring an additional 91 shares during the period. Central Pacific Bank Trust Division raised its position in STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its stake in STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 137 shares during the period. Hedge funds and other institutional investors own 94.69% of the company's stock.

Wall Street Analysts Forecast Growth

STE has been the topic of a number of recent research reports. JMP Securities restated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday. Stephens reaffirmed an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a research note on Monday. Finally, Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, STERIS presently has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

Remove Ads

STERIS Stock Performance

STE traded up $4.06 during trading on Friday, reaching $221.18. The company's stock had a trading volume of 459,313 shares, compared to its average volume of 535,698. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The company's fifty day moving average price is $222.61 and its 200-day moving average price is $219.62. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a market capitalization of $21.73 billion, a price-to-earnings ratio of 46.96 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.